FDA approves Arnuity Ellipta as prophylactic therapy of asthma in children aged 5 to 11 years May 23, 2018
Sublimity Therapeutics closes financing to fund development of STI-0529 in ulcerative colitis May 23, 2018
Acceleron initiates phase II PULSAR study of sotatercept in pulmonary arterial hypertension May 23, 2018
RSS